Cortistatin: Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides →
📌TL;DR
- •1 community protocols documented
- •Evidence level: Anecdotal Reports
- •Based on 5 community reports
- •Stacking patterns detailed below
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Availability | All cortistatin research is preclinical, conducted in cell culture and animal models. No human clinical trials have been conducted. Studies focus on slow-wave sleep promotion, anti-inflammatory effects in IBD and sepsis models, and cortical excitability regulation. | Cortistatin is essentially unavailable from research peptide vendors. Its structural similarity to somatostatin and complex cyclic structure make it expensive to synthesize. Virtually no community experimentation exists. | high The near-complete absence of cortistatin from vendor catalogs means that community protocols are theoretical rather than based on actual user experience. |
| Research Context | Preclinical research shows cortistatin selectively promotes deep slow-wave sleep (unlike somatostatin, which does not), exerts potent anti-inflammatory effects through distinct receptor interactions, and modulates cortical activity. It binds all somatostatin receptors plus the ghrelin receptor (GHSR-1a). | Community interest is primarily theoretical, driven by cortistatin's unique sleep-promoting properties that distinguish it from the structurally similar somatostatin. | high While cortistatin has interesting preclinical properties, the absence of human data and commercial availability makes community adoption impractical at present. |
Compare these community approaches with published research findings.
Community Protocols
Theoretical Sleep Protocol
Niche- Route
- Subcutaneous
- Dose
- 50-200 mcg
- Frequency
- Once daily before bed
- Duration
- 2-4 weeks
Extremely limited community use; doses extrapolated from preclinical literature and related somatostatin dosing
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 5+ self-experimenters report. Free with email.
150+ peptide profiles · 30+ comparisons · 18 research tools
Sources
- Reddit r/Peptides|Cortistatin discussion threads (primarily theoretical)(accessed 2026-02-16)
- Reddit r/Nootropics|Cortistatin and sleep peptide discussions(accessed 2026-02-16)
Community Evidence Overview#
This page presents information about Cortistatin in the context of community peptide use. This is not clinical evidence and should not be used as medical guidance.
Cortistatin has virtually no community usage. Despite interesting preclinical properties (selective slow-wave sleep promotion, potent anti-inflammatory effects), cortistatin is not available from research peptide suppliers and has never been tested in humans. This page exists primarily for informational purposes.
Why No Community Adoption#
Several factors explain the absence of community experimentation with cortistatin:
- Unavailability: Not synthesized or sold by research peptide vendors
- Complex structure: The cyclic disulfide bond makes synthesis expensive
- Preclinical only: No human data of any kind exists
- Competition: DSIP and other sleep peptides are more accessible for those seeking sleep-promoting peptides
- Somatostatin overlap: Binding to all somatostatin receptors could have undesirable hormonal effects (GH suppression)
Important Caveats#
- All cortistatin research is preclinical
- The peptide is not commercially available
- Somatostatin receptor activation could suppress growth hormone
- No safety data in humans exists
Related Reading#
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles · 30+ comparisons · 18 research tools
Frequently Asked Questions About Cortistatin
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.